Reports to: Group Technical Manager
Role Summary: Working as part of the Pharmaceutical Development Team at Quay to deliver analytical development programmes.
- To work closely with the project managers and team leaders to provide the technical and scientific oversight for projects.
- To deliver scientifically sound drug substance characterization and analytical development and validation protocols.
- To act as technical support for the analytical team.
- To author analytical development reports and presentations to document investigational findings.
- To maintain effective communication with all key stakeholders.
- To participate in client facing meetings (on site meetings and TCs).
- To participate in CPD activities to develop scientific knowledge further, for example, by attending relevant symposia/conference meetings and to disseminate this information to other members of the technical team.
- To perform other duties required in a technical capacity as required by the business.
- To perform data review, investigations and analytical problem solving using appropriate root cause analysis techniques.
Educated to degree level with BSc/MSc Analytical Chemistry/Pharmaceutical sciences/Molecular biology or relevant chemistry/biochemistry related discipline. Further postgraduate qualifications would be an advantage.
A minimum of 5 to 10 years’ experience in an analytical method development role, or relevant research and development experience for biochemistry is desired, preferably working in the service regulated pharmaceutical industry.
A proven track record in small molecule analytical development to support non-sterile dosage form development is a pre-requisite. Expertise in stability-indicating method development techniques using reverse and normal phase chromatographic techniques including experience in the development of in-vitro release methodology for modified release dosage forms is essential.
The ideal candidate will also have experience in the development and routine use of cell counting methods including counting chambers, automated plate counting methods and flow cytometry. Experience in development and routine use of ELISA methods would be highly advantageous.
NO AGENCIES PLEASE